| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |